CYBA C242T polymorphism is associated with obesity and diabetes mellitus in Brazilian hypertensive patients


Autoria(s): Schreiber, R.; Ferreira-Sae, M. C.; Tucunduva, A. C.; Mill, J. G.; Costa, Felipe O.; Krieger, J. E.; Franchini, K. G.; Pereira, A. C.; Nadruz, W., Jr.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

27/09/2013

27/09/2013

2012

Resumo

Diabet. Med. 29, e55e61 (2012) Abstract Aims The CYBA C242T polymorphism has been associated with cardiovascular phenotypes such as hypertension and atherosclerosis, but available data are conflicting. This report investigated the impact of this variant on hypertension and metabolic determinants of cardiovascular risk in a large Brazilian sample. Methods We cross-sectionally evaluated 1856 subjects (826 normotensive subjects and 1030 hypertensive patients) by clinical history, anthropometry, laboratory analysis and genotyping of the CYBA C242T polymorphism. Results Genotype frequencies in the whole population were consistent with the HardyWeinberg equilibrium and genotype distributions were not different between hypertensive and normotensive subjects. Hypertensive patients with the CC genotype presented lower fasting plasma glucose levels (5.9 +/- 0.1 vs. 6.2 +/- 0.1 mmol/l, P = 0.020) and waist circumference (94.5 +/- 0.6 vs. 96.3 +/- 0.6 cm, P = 0.028) than CT + TT ones. Similarly, the prevalence of diabetes mellitus and obesity was also lower in hypertensive patients carrying the CC genotype (16% vs. 21%, P = 0.041; 36% vs. 43%, P = 0.029, respectively). In addition, multiple and logistic regression analysis demonstrated that the CYBA C242T polymorphism was associated with glucose levels, waist circumference, obesity and diabetes mellitus in hypertensive patients independently of potential confounders. Conversely, in normotensive subjects, no significant difference in studied variables was detected between the genotype groups. Conclusions These data suggest that the T allele of the CYBA C242T polymorphism may be used as a marker for adverse metabolic features in Brazilian subjects with systemic hypertension.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/16252-0]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474966/2010-0]

Identificador

DIABETIC MEDICINE, HOBOKEN, v. 29, n. 7, pp. E55-E61, JUL, 2012

0742-3071

http://www.producao.usp.br/handle/BDPI/33773

10.1111/j.1464-5491.2012.03594.x

http://dx.doi.org/10.1111/j.1464-5491.2012.03594.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

HOBOKEN

Relação

DIABETIC MEDICINE

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #DIABETES MELLITUS #HYPERTENSION #METABOLIC PROFILE #NADPH OXIDASE #SINGLE NUCLEOTIDE POLYMORPHISM #CORONARY-ARTERY-DISEASE #P22 PHOX GENE #NADPH OXIDASE #OXIDATIVE STRESS #NAD(P)H OXIDASE #P22PHOX C242T #WEIGHT-GAIN #P22(PHOX) #POPULATION #RISK #ENDOCRINOLOGY & METABOLISM
Tipo

article

original article

publishedVersion